单重免疫检测市场规模、份额和成长分析：按检测法、产品类型、目标分析物、应用、地区和产业预测，2026-2033年

2024年全球单重免疫检测市值为2.021亿美元，预计将从2025年的2.0917亿美元成长到2033年的2.7544亿美元。预测期（2026-2033年）的复合年增长率预计为3.5%。

全球单重免疫检测市场专注于针对感染疾病临床决策所需关键个体生物标记的诊断测试。该市场以高分析灵敏度和完善的法规结构为特征，巩固了单分析物检测在急诊护理中的黄金标准地位。从手动ELISA试剂盒到自动化平台的演变，随着主要企业不断推动创新，处理能力和一致性得到了显着提升。精准诊断解决方案的激增需求凸显了单标靶检测（例如肌钙蛋白检测）在改善患者管理方面的重要性。技术进步，尤其是在人工智慧领域，透过特异性试剂选择和流程效用，正在提高检测灵敏度和处理能力。这推动了分散式检查的发展，展现了其在新兴市场和治疗监测中的持续价值。

推动全球单重免疫检测市场发展的因素

全球单重免疫检测市场的主要驱动力是消费者对快速、精准的诊断测试日益增长的需求，这些测试专注于检测单一分析物。这些免疫检测简化了工作流程，有助于改善临床决策并优化检查室流程。它们能够以少量检体快速提供结果，因此在分散式和照护现场环境中备受青睐，满足了需要即时获得可操作资讯（例如检测结果）的医疗专业人员的需求。这些标靶测试的效用正在提高市场接受度，促使医院和诊所采用这些测试方法，并促使供应商投资其产品供应链。因此，製造商正日益专注于开发和分销这些重要的诊断工具，以满足临床需求。

全球单重免疫检测市场的限制因素

专用抗体、试剂和单项分析试剂盒的高成本对全球单重免疫检测市场构成重大挑战。这些高成本推高了检查室和医疗机构的单次检测费用，可能会抑制采购，尤其是在预算有限的情况下。因此，许多机构可能会优先考虑购买多方法或整合平台，因为这些平台似乎能提供更高的单次检测成本效益。这种经济压力可能会阻碍资源匮乏环境下的推广应用，减少小规模实验室的投资，最终限制市场成长，并促使製造商采取降低成本的策略。

全球单重免疫检测市场趋势

在全球单重免疫检测市场中，工作流程整合和自动化正成为一种显着趋势，这主要受检查室和照护现场环境中对易用性和快速结果的需求不断增长的驱动。开发人员正致力于开发精简的检测方法和紧凑型分析仪，从而提升诊断处理能力，并提高临床医师的使用便利性。检测製造商与临床检查室之间的策略合作进一步强化了这一趋势，这些合作优先考虑使用者培训以及与实验室资讯系统的有效整合。因此，市场正在向各种医疗保健环境扩展，以支援扩充性并降低操作复杂性。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球单重免疫检测市场规模：依检测法及复合年增长率划分（2026-2033 年）

• 酵素免疫分析法
• 侧向流检测法
• 萤光免疫分析
• 化学冷光免疫检测

全球单重免疫检测市场规模：依产品类型及复合年增长率划分（2026-2033 年）

• 成套工具
• 试剂
• 装置

全球单重免疫检测市场规模：依目标分析物及复合年增长率划分（2026-2033 年）

• 蛋白质
• 荷尔蒙
• 抗体
• 病原

全球单重免疫检测市场规模：依应用及复合年增长率划分（2026-2033 年）

• 临床应用
• 研究用途
• 医疗用途
• 其他的

全球单重免疫检测市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Abbott Laboratories
• Roche Diagnostics
• Thermo Fisher Scientific
• Siemens Healthineers
• Bio-Rad Laboratories
• Ortho Clinical Diagnostics
• PerkinElmer
• Quidel Corporation
• Danaher Corporation
• Agilent Technologies
• Merck KGaA
• GenScript Biotech Corporation
• Becton, Dickinson and Company
• EMD Millipore
• Sysmex Corporation
• Fujifilm Wako Pure Chemical Corporation
• Miltenyi Biotec
• Tecan Group
• DiaSorin SpA
• Abcam plc

结论与建议

Global Singleplex Immunoassay Market size was valued at USD 202.1 Million in 2024 and is poised to grow from USD 209.17 Million in 2025 to USD 275.44 Million by 2033, growing at a CAGR of 3.5% during the forecast period (2026-2033).

The global singleplex immunoassay market focuses on diagnostic tests targeting individual biomarkers, vital for informed clinical decision-making in infectious diseases. This market is characterized by high analytical sensitivity and established regulatory frameworks, solidifying single analyte tests as the gold standard for acute care. The evolution from manual ELISA kits to automated platforms has enhanced throughput and consistency, with major players driving innovations. The demand for precise diagnostic solutions has surged, highlighting the significance of single target tests like troponin assays in improving patient management. Advancements in technology, particularly in AI, are enhancing assay sensitivity and throughput by optimizing reagent selection and automating processes. This paves the way for growth in decentralized testing, improving utility in emerging markets and therapeutic monitoring, showcasing the ongoing value of focused assays.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Singleplex Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Singleplex Immunoassay Market Segments Analysis

Global singleplex immunoassay market is segmented by assay types, product type, target analyte, application and region. Based on assay types, the market is segmented into Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay, Fluorescent Immunoassay and Chemiluminescent Immunoassay. Based on product type, the market is segmented into Kits, Reagents and Instruments. Based on target analyte, the market is segmented into Proteins, Hormones, Antibodies and Pathogens. Based on application, the market is segmented into Clinical Applications, Research Applications, Healthcare Applications and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Singleplex Immunoassay Market

The Global Singleplex Immunoassay market is significantly influenced by the increasing demand for rapid and precise diagnostic tests that facilitate focused detection of individual analytes. These immunoassays offer straightforward workflows, enhancing clinical decision-making and optimizing laboratory processes. Their ability to work with small sample volumes and provide quicker results makes them highly favored in decentralized and point-of-care environments, catering to healthcare professionals who require immediate actionable insights. This practical relevance for targeted testing encourages hospitals and clinics to procure these assays, prompting suppliers to invest in product availability and thereby boosting market acceptance. As a result, manufacturers are increasingly focused on developing and distributing these essential diagnostic tools to address clinical requirements.

Restraints in the Global Singleplex Immunoassay Market

The high expenses related to specialized antibodies, reagents, and single-analyte assay kits present a significant challenge for the Global Singleplex Immunoassay market. These elevated costs raise the per-test expenditure for laboratories and healthcare providers, potentially deterring them from procurement, particularly when budget constraints are a factor. Consequently, many institutions may prioritize purchasing multiplex approaches or consolidated platforms that seem more cost-effective per test. This financial pressure can hinder adoption in environments with limited resources and may reduce investment from smaller laboratories, ultimately restricting market growth and influencing manufacturers to adopt strategies aimed at cost reduction.

Market Trends of the Global Singleplex Immunoassay Market

The Global Singleplex Immunoassay market is experiencing a significant trend towards workflow integration and automation, driven by a growing demand for ease of use and rapid results in both laboratory and point-of-care settings. Developers are concentrating on creating streamlined assay formats and compact analyzers, which enhance diagnostic throughput and increase accessibility for clinicians. This trend is further bolstered by strategic partnerships between assay manufacturers and clinical laboratories that prioritize user training and efficient integration with laboratory information systems. Consequently, the market is witnessing an expansion into diverse healthcare environments, supporting scalability and reducing operational complexities.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Singleplex Immunoassay Market Size by Assay Types & CAGR (2026-2033)

• Market Overview
• Enzyme-Linked Immunosorbent Assay
• Lateral Flow Assay
• Fluorescent Immunoassay
• Chemiluminescent Immunoassay

Global Singleplex Immunoassay Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Kits
• Reagents
• Instruments

Global Singleplex Immunoassay Market Size by Target Analyte & CAGR (2026-2033)

• Market Overview
• Proteins
• Hormones
• Antibodies
• Pathogens

Global Singleplex Immunoassay Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Applications
• Research Applications
• Healthcare Applications
• Others

Global Singleplex Immunoassay Market Size & CAGR (2026-2033)

• North America (Assay Types, Product Type, Target Analyte, Application)
  • US
  • Canada
• Europe (Assay Types, Product Type, Target Analyte, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Assay Types, Product Type, Target Analyte, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Assay Types, Product Type, Target Analyte, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Assay Types, Product Type, Target Analyte, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EMD Millipore
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Wako Pure Chemical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations